Litigation Details for Federal Trade Commission v. U.S. Anesthesia Partners, Inc. (S.D. Tex. 2023)
✉ Email this page to a colleague
Federal Trade Commission v. U.S. Anesthesia Partners, Inc. (S.D. Tex. 2023)
Docket | ⤷ Try a Trial | Date Filed | 2023-09-21 |
Court | District Court, S.D. Texas | Date Terminated | |
Cause | 15:0045 Federal Trade Commission Act | Assigned To | Kenneth M. Hoyt |
Jury Demand | None | Referred To | |
Patents | 6,002,008; 6,503,894; 7,935,008; 8,008,003; RE37,516 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Federal Trade Commission v. U.S. Anesthesia Partners, Inc.
Biologic Drugs cited in Federal Trade Commission v. U.S. Anesthesia Partners, Inc.
Details for Federal Trade Commission v. U.S. Anesthesia Partners, Inc. (S.D. Tex. 2023)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2024-01-19 | 119 | Second Appendix of Authorities | No. 6,503,894 ('894 patent). Although exclusivity upon FDA approval, which is similar to…Generics within the forty-five day window of patent, drug patents grant brand name manufacturers a legal … a similar schedule. FDA, (2) the patent has expired, (3) the patent will expire on a …holder of the ANDA. 6 If the patent holder decides to file patent as well as claims construction…issued a patent on ANDA with a Paragraph IV certification receives generic AndroGel, U.S. Patent No. | External link to document |
2024-04-05 | 132 | FTC Appendix of Authorities | 05/02/08 Opposition, if any 06/02/08 Reply, if any 06/20/08…the patent at issue in the litigation expires. As a result of the parties’ settlement, the patent case… Patent”), No. 8,450,249 (“the '249 Patent”), and No. … 8,450,250 (“the '250 Patent”) (collectively, “the Patents-in- Only the Westlaw citation… patents, and that Lubrizol's patents are unenforceable due Wickliffe | External link to document |
2023-11-06 | 81 | Appendix Appendix of Authorities | particles. This patent first issued in 1997 and re-issued in 2002 as U.S. Patent No. RE37,516 (the “Particle…notify the patent holder of the filing of its ANDA. If the patent holder initiates a patent infringement… only then-remaining patent that covered Provigil, a narrow formulation patent relating to the size of…version does not infringe the patents on the brand-name drug, or (2) the patents are invalid. This is referred… the earliest of (1) patent expiry, (2) district court resolution of the patent litigation in favor of | External link to document |
2023-11-20 | 98 | Appendix | 8,414 7,935 8,153 479 …. 1966) (holding compulsory licensing of patents is reasonable where substantive evidence indicates… merger occurred, and because defendant's patents would always tend to limit competition anyway | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |